Loading company…
Soley Therapeutics uses cell analysis, imaging and AI to discover drug candidates.
Founded in 2020 and based in South San Francisco, Soley Therapeutics uses human cells, imaging, AI and automation for drug discovery. Its research targets unmet needs including oncology and regenerative medicine. In January 2026, it raised USD 200.00 mn in Series C funding led by Surveyor Capital. The company plans to advance an AML program into clinical trials and progress a solid tumor candidate to IND-enabling studies.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in